The UK's National Health Service just approved a drug that costs nearly $2.5 million a dose

Retrieved on: 2021-03-08 14:33:48

Tags for this article:

Click the tags to see associated articles and topics

The UK's National Health Service just approved a drug that costs nearly $2.5 million a dose. View article details on hiswai:

Excerpt

The innovative gene therapy called "Zolgensma" does not come cheap, with a reported list price of £1.79 million ($2.48 million) per dose.

Article found on: www.cnbc.com